09 Nov Circulating Myeloid-Derived Suppressor Cells and Neutrophil- and Platelet-Lymphocyte Ratio predict clinical efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer
Posted at 01:53h
in Precision immunotherapy
ID: 2585
Autores: Benet Giménez, Marta (0); Benet, Marta (1); García, José (2); Piqueras, Marta (1); Cordón, Lourdes (3); De Julián, María (4); Garde, Javier (2); Sánchez, Alfredo (4); Lorente, David (4); Suai, Guillermo (1,5); Aparisi, Francisco (1,5); Juan, Óscar (1,5); Lahoz, Agustín (1)
Temática: Precision immunotherapy
Leer completo